Abstract

Compounding of DMSA Radiopharmaceutical Kits During a Shortage 

Author(s): Galbraith Wendy, Baumgartner Megan, Talley Katie, Keith Desirie, Dolan GT, Gali Hariprasad

Issue: Nov/Dec 2025 - Volume 29, Number 6

Page(s): 520-528

Download in electronic PDF format for $75
  • Compounding of DMSA Radiopharmaceutical Kits During a Shortage  Page 1
  • Compounding of DMSA Radiopharmaceutical Kits During a Shortage  Page 2
  • Compounding of DMSA Radiopharmaceutical Kits During a Shortage  Page 3
  • Compounding of DMSA Radiopharmaceutical Kits During a Shortage  Page 4
  • Compounding of DMSA Radiopharmaceutical Kits During a Shortage  Page 5
  • Compounding of DMSA Radiopharmaceutical Kits During a Shortage  Page 6
  • Compounding of DMSA Radiopharmaceutical Kits During a Shortage  Page 7
  • Compounding of DMSA Radiopharmaceutical Kits During a Shortage  Page 8
  • Compounding of DMSA Radiopharmaceutical Kits During a Shortage  Page 9

Abstract

Succimer (meso-2,3-dimercaptosuccinic acid, DMSA) commercial manufacturing was discontinued for 5.5 years from 2016 to 2022. This radiopharmaceutical is used in our academic health center as standard of care for diagnosing and staging renal scarring. Our objective was to validate a method to verify the content of DMSA in a cold reaction vial, referred to hereafter as a kit, after compounding in a nuclear pharmacy. Methods: A simplified method of DMSA kit compounding was performed by passing a saturated solution of DMSA in sterile water for injection through a 0.22-micron filter after the addition of all other kit components. To verify DMSA content, we used Ellman’s Reagent, 5,5’-dithio-bis-(2-nitrobenzoic acid). This compound reacts with a free thiol group at pH - 8 to produce a yellow-colored mixed disulfide product with a strong absorbance at 412 nm. A calibration curve was prepared using DMSA solutions of known concentrations and used to determine the molar concentration of DMSA in a kit. The kits were stored frozen and DMSA content was verified over 45 days. Results: All kits met the acceptance criteria of the USP monograph for technetium 99m succimer for administration. Statistical analysis with 0.95 power and using mean standard deviation resulted in a 95% confidence interval within ±10% of DMSA labeled content by sampling 4 vials of a batch using the Ellman’s Reagent test. Kits have shown stability over 45 days frozen.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2025
Pg. 520-528
May/Jun 2004
Pg. 181-185
Jul/Aug 2004
Pg. 269-274
Mar/Apr 2023
Pg. 94-96
May/Jun 2004
Pg. 206-209
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 238-246
Jan/Feb 2014
Pg. 6-12
Jul/Aug 2003
Pg. 281-285
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Author(s): Allen Loyd V Jr
Sep/Oct 2016
Pg. 367-374
Mar/Apr 2013
Pg. 168-174
Jul/Aug 2022
Pg. 298-301
Author(s): Ofei Kelvin
Sep/Oct 2018
Pg. 387-398
Jul/Aug 1999
Pg. 309-310
Author(s): Allen Loyd V Jr
Mar/Apr 1997
Pg. 71-74
Author(s): Allen Loyd V Jr
Nov/Dec 2003
Pg. 460-463
View Sample
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 289-291
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 265-267
Author(s): Wynn Tom
Mar/Apr 1997
Pg. 132-134
Mar/Apr 2022
Pg. 118-126
Author(s): Allen Loyd V Jr